Alembic Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

04 Mar 2021 | 03:59 PM

922.00
-7.20 (-0.77%)

  • Underperforms Index

    41.8%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 13.05%

  • More Volatile

    3.07%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.35%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,150

1,150.00

436

436.10

News & Announcements

Price vs Volume

Stock Trivia

  • MF shareholding in Alembic Pharmaceuticals Ltd has decreased by -8.1% since past 3 Months

  • FII shareholding in Alembic Pharmaceuticals Ltd has decreased by -24.63% since past 1 Year

  • MF shareholding in Alembic Pharmaceuticals Ltd has increased by 12.54% since past 1 Year

  • Promoter shareholding in Alembic Pharmaceuticals Ltd has decreased by -4.37% since past 1 Year

Loading...